INCREASING THE EFFECTIVENESS OF COMPREHENSIVE DIAGNOSIS AND TREATMENT OF PATIENTS WITH CHRONIC RHINOSINUSITIS IN THE CONTEXT OF COVID-19.
Article Sidebar
Main Article Content
Abstract
The COVID-19 pandemic has significantly complicated the diagnosis and management of chronic rhinosinusitis (CRS), highlighting the need for a comprehensive, multidisciplinary approach. This review emphasizes current strategies to enhance diagnostic accuracy and treatment efficacy for CRS patients during and after the pandemic. It explores the influence of SARS-CoV-2 on sinonasal pathology, discusses innovative diagnostic tools, and reviews tailored therapeutic options, including conservative management and surgical interventions. Addressing challenges posed by COVID-19 is vital for improving patient outcomes, reducing recurrences, and optimizing healthcare resource utilization. The review synthesizes recent scientific evidence to guide clinicians in delivering effective, individualized care in this evolving landscape.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
How to Cite
References
1.Zhang, Q., & Sun, L. (2023). Recent advances in diagnosing and managing CRS during COVID-19. Clinical Otolaryngology, 48(1), 45-55.
2.Chen, Y., et al. (2022). Telemedicine applications in sinonasal disorders: A COVID-19 perspective. European Archives of Oto-Rhino-Laryngology, 279(12), 6075-6084.
3.Lee, M. H., & Kim, S. H. (2021). Impact of SARS-CoV-2 on sinonasal epithelial cell response in CRS. Virus Research, 294, 198283.
4.Patel, V., & Sharma, G. (2020). Safety protocols in endoscopic sinus surgery during COVID-19. Laryngoscope, 130(10), 2330-2335.
5.Rodriguez, A., et al. (2021). Biomarkers for CRS in the era of COVID-19: Diagnostic and prognostic implications. Current Allergy and Asthma Reports, 21(8), 46.
6.Wang, Y., & Li, H. (2022). Emerging diagnostic technologies in ENT in response to COVID-19. Frontiers in Medicine, 9, 808664.
7.Kumar, S., & Singh, S. (2021). Long-term outcomes in CRS patients post-COVID-19. International Journal of Otolaryngology, 2021, 9945232.
8.Saito, H., & Tanaka, Y. (2019). Nasal endoscopy innovations and safety guidelines amid pandemic. Otolaryngology–Head and Neck Surgery, 161(4), 542-548.
9.Wu, Y., & Zhang, Q. (2022). The role of AI and machine learning in CRS diagnosis during COVID-19. Artificial Intelligence in Medicine, 124, 102174.
10.Van Zandvoort, S., et al. (2021). Diagnostic algorithms for CRS under pandemic constraints. JAMA Otolaryngology–Head & Neck Surgery, 147(1), 7-14.
11.Balasubramanian, S., & Patel, D. (2020). Pharmacological management of CRS in COVID-19 era. American Journal of Rhinology & Allergy, 34(6), 738-744.
12.Sormani, M. P., et al. (2022). Long-term outcome of CRS patients treated during COVID-19: A multicenter study. * European Archives of Oto-Rhino-Laryngology*, 279, 3775–3784.
13.Singh, S., & Gupta, A. (2021). Innovations in diagnostic imaging for CRS amidst COVID-19 guidelines. Journal of Otolaryngology - Head and Neck Surgery, 50, 65.